SNMMI-TS Quality and Safety Series, Book #1 Member Fee: $149.00 Non-Member Fee: $225.00 Release Date: January 1, 2017 Expiration Date: January 31, 2020
Target Audience This article contains information of value to nuclear medicine technologists. Description/content: This is a comprehensive book focusing on ways to improve quality, increase safety, and reduce radiation burden in myocardial perfusion imaging. It is designed as an easy reference that will give new insights to even the most tenured technologists. Each chapter explains general guidelines, offering more depth where needed. It is written by nuclear medicine technologists and physicians who have in-depth knowledge of all of the complexities of nuclear cardiology. It is written so to be understandable and useful to all levels of nuclear medicine professionals. The full list of objectives follows below. Chapters include: - Introduction and Overview - Patient Preparation and Education - Stress Testing - Radiopharmaceuticals - Quality Control - Imaging Protocols - Acquisition - Processing - Artifacts - Basic Interpretation - Future of Myocardial Perfusion Imaging
Continuing Education Credit Information
Minimum system requirements Supported Internet Browsers: - Microsoft Internet Explorer (version 9 or higher) - Google Chrome (latest version) - Mozilla Firefox (latest version) - Apple Safari (version 4 or higher) Plug-in: Adobe Acrobat Reader (http://get.adobe.com/reader/) For questions please contact the Education Department at Education@snmmi.org.
© 2017 SNMMI. All rights reserved. Policy on Privacy and Confidentiality: http://www.snmmi.org/index.cfm?PageID=926 Chapter 2: • Explain the required patient preparation protocol for myocardial perfusion imaging • List contraindications for myocardial perfusion imaging studies • Describe the correct patient identification protocol for patient studies Chapter 3: Note: question #2 should be corrected to read: A contraindication for an exercise stress... • Describe metabolic equivalent and how it is applied in myocardial stress testing • List pharmacological agents and their metabolic actions used in pharmacological stress tests • Identify contraindications associated with pharmacological stress agents Chapter 4: • List the appropriate imaging times after injection for thallium, technetium and PET imaging agents • Describe and compare imaging agents used for myocardial viability versus myocardial perfusion imaging • Compare radioactive half lives and energy ranges of currently approved myocardial imaging agents Chapter 5: • List characteristic appearances of camera uniformity problems found during uniformity testing • Describe center-of-rotation and its possible impact on myocardial imaging procedures when alignment errors are present • Explain the application of the Jaszczak phantom in assessing resolution, contrast and uniformity in SPECT imaging. Chapter 6: • Describe the timing sequence for performing one and two-day rest/stress myocardial perfusion protocols with 99mTc imaging agents • Compare myocardial viability studies using 201Tl and 18F-FDG • Review radiation exposure associated with thallium, technetium and PET imaging agents Chapter 7: • Describe energy spatial and contrast resolution and its impact on myocardial imaging • Explain collimation and how different collimators are selected and used for myocardial imaging • Compare SPECT and PET detectors used in myocardial imaging Chapter 8: • Describe the reconstruction of tomographic images acquired during myocardial SPECT imaging • Explain imaging filtering/selection as it relates to noise reduction and feature enhancement • Describe the assignment of perfusion scores as it relates to relative flow quantification Chapter 9: • Describe image findings associated with vertical and horizontal imaging artifacts • Explain how to identify/assess motion artifacts post imaging • List common attenuation artifacts and recommended techniques to reduce or eliminate them during SPECT imaging Chapter 10: • Describe the calculation and reporting of summed scores in myocardial imaging • Define sensitivity and specificity in myocardial perfusion imaging • Explain the application of risk stratification as it applies to the clinically relevant interpretation of a MPI study Chapter 11: • Describe and compare new radiotracers proposed for MPI • List external challenges facing cardiac nuclear medicine • Explain how solid-state technology may revolutionize myocardial perfusion SPECT.